Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Animal models are those animals on which pathological and biological experiments are performed and tested. Animal models are implemented as animal and human beings share important physiological & organic structure. Furthermore, some of the animal’s species have similar genetic structure as humans. So, animal models are used by scientists and researcher to study and find cure for diseases, test the final medicinal drugs before it is used on humans and also for development of new products. Novel drugs are examined in animals for their safety and efficacy prior examination in humans.
The United States humanized mouse models market is observing rapid growth during the forecast period of 2019 to 2028. The animal models are used for drug discovery and development, basic research and others. The dynamic factor such as use of animal model in validation and target identification, toxicity and safety screening, drug screening and lead optimization is boosting growth of United States humanized mouse models market. Increasing demand for animal model for performing various studies is also propelling growth of United States humanized mouse models market. However, stringent regulatory framework is hindering growth of United States humanized mouse models market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the humanized mouse models market. In addition, complete analysis of changes on humanized mouse models expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period.
The United States humanized mouse models market is bifurcated into type, application and end user.
Based on type, the United States humanized mouse models market is segmented into cell-based humanized mouse market and genetic humanized mouse models market. In which genetic humanized mouse models are likely to dominate the market in 2020. The increasing use of genetic models for analysis of compounds, biological efficacy and safety testing is also boosting growth of humanized mouse models market. The rising investigational study for new drug development is also propelling growth of humanized mouse models market.
Based on application, the United States humanized mouse models market is bifurcated into the immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other. In which immunology and infectious disease segment is estimated to dominate the market in 2020. The increasing number of cancer research centres is propelling growth of United States humanized mouse models market. The rising research and development activities is also boosting growth of United States humanized mouse models market.
Based on end user, the United States humanized mouse models market is categorised into the pharmaceutical and biotechnology companies, contract research organizations and academic and research institution. In which contract research organizations is also contributing in the growth of United States humanized mouse models market. The increasing prevalence of infectious diseases is propelling growth of United States humanized mouse models market. The growing use of humanized mouse models for cancer research is also refuelling growth of United States humanized mouse models market.
The major key players in humanized mouse models market are The Jackson Laboratory, Taconic Biosciences Inc., Harbour Biomed, Humurine Technologies Inc., Vitalstar Biotechnology Co. Ltd., Crown Bioscience Inc., Ingenious Targeting Laboratory, Axenis S.A.S., Trans Genic Inc. and Genoway S.A. among others.
January 2021: The Champion Oncology Inc., a well-known global oncology technology company which is transforming drug discovery and development by the data driven research strategies announced the expansion of its Lumin Bioinformatics SaaS program.
December 2020: The Perkin Elmer Inc., and Horizon Discovery Group plc announced the agreement on the terms of a recommended all-cash offer in Perkin Elmer will acquire Horizon.
January 2020: The Taconic Biosciences, a global leader in the development of drug discovery animal model has launched a new model generation facility in Leverkusen, Germany.
January 2020: The H.I.G. Capital announced that one of their affiliates has joined forces with the management team of Taconic Biosciences inc., for supporting company’s growth as the leading provider of research models and services to the pharmaceutical, biotechnology and contract research organizations.
The report analyses the humanized mouse models based on the type, application and end user. The various types of humanized mouse models covered in the report are genetic humanized mouse models and cell-based humanized mouse models. By Application, the market is segmented into the immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other. Based on end user, the market is segmented into the pharmaceutical and biotechnology companies, contract research organization and academic and research institutes. The report also analyses the impact of COVID-19 on the market and it found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period. The report also analyses the major key players operating in the market.
Why to buy this report:
